Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Emmaus Life Sciences, Inc. (EMMA) had Revenue of $6.32M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$6.32M
Net Income	$1.34M
Cost of Goods Sold	$0.34M
Gross Profit	$5.97M
Operating Expenses	$2.53M
Operating Income	$3.79M
Non-Operating Income/Expense	$-2.45M
Pre-Tax Income	$1.34M
Normalized Pre-Tax Income	$2.07M
Income after Taxes	$1.34M
Income from Continuous Operations	$1.34M
Consolidated Net Income/Loss	$1.34M
Normalized Income after Taxes	$2.07M
EBIT	$3.79M
EBITDA	$3.92M
Weighted-Average Shares Outstanding (Basic)	70.19M
Weighted-Average Shares Outstanding (Diluted)	120.54M
Earnings per Share (EPS) (Basic)	$0.02
Earnings per Share (EPS) (Diluted)	$0.02
Balance Sheet Financials
Current Assets	$6.00M
Property, Plant, and Equipment	$0.09M
Long-Term Assets	$10.37M
Total Assets	$16.37M
Current Liabilities	$66.12M
Long-Term Debt	$2.25M
Long-Term Liabilities	$16.43M
Total Liabilities	$82.55M
Common Equity	$-66.18M
Tangible Shareholders Equity	$-66.18M
Shareholders Equity	$-66.18M
Common Shares Outstanding	70.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.35M
Cash Flow from Investing Activities	$1.58M
Cash Flow from Financial Activities	$-2.24M
Beginning Cash	$2.13M
End Cash	$2.81M
Increase/Decrease in Cash	$0.68M
Stock-Based Compensation	$0.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.04
Debt to Equity Ratio	-0.44
Gross Margin	94.56%
Operating Margin	60.00%
EBIT Margin	60.00%
EBITDA Margin	--
Pre-Tax Profit Margin	21.18%
Profit Margin	21.19%
Free Cash Flow	$1.35M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	0.22
Receiveable Turnover	8.91
Days Sales in Receivables	10.10
Return on Equity	-2.02%
Return on Tangible Equity	-2.02%
Return on Assets	8.18%
Return on Investments	-2.09%
Book Value Per Share	$-0.94
Free Cash Flow per Share	$0.01
Operating Cash Flow per Share	$0.01

Data from Zacks Investment Research, Inc.